TD Cowen Keeps Their Buy Rating on Xilio Therapeutics (XLO)
TD Cowen analyst Marc Frahm maintained a Buy rating on Xilio Therapeutics (XLO – Research Report) today. The company’s shares ...
TD Cowen Sticks to Its Buy Rating for Elevation Oncology (ELEV)
In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Elevation Oncology (ELEV – Research Report). The ...